RankingsPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Earnings per share

Immuno-Biological Laboratories Co., Ltd.【JP:4570】

Market cap
¥17B
P/E ratio
64x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 202526.7+33.37%
Mar 31, 202420.1-164.47%
Mar 31, 2023-31.1+11.95%
Mar 31, 2022-27.8-18.84%
Mar 31, 2021-34.2-54.96%
Mar 31, 2020-76+283.45%
Mar 31, 2019-19.8+182.74%
Mar 31, 2018-7-97.56%
Mar 31, 2017-287.5+5816.05%
Mar 31, 2016-4.9-79.92%
Mar 31, 2015-24.2+34.52%
Mar 31, 2014-18-172.45%
Mar 31, 201324.8+257.78%
Mar 31, 20126.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)